First Header Logo Second Header Logo

Robert Stratta

Concepts (336)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Kidney Transplantation
69
2020
348
13.790
Why?
Pancreas Transplantation
42
2018
80
9.690
Why?
Tissue Donors
30
2018
167
6.440
Why?
Graft Rejection
35
2019
149
5.620
Why?
Graft Survival
32
2020
228
3.710
Why?
Immunosuppressive Agents
22
2019
167
3.640
Why?
Tissue and Organ Procurement
13
2018
69
3.230
Why?
Delayed Graft Function
9
2020
33
2.820
Why?
Immunosuppression
16
2019
80
2.740
Why?
Kidney Failure, Chronic
15
2018
518
2.590
Why?
Antilymphocyte Serum
8
2015
17
1.830
Why?
Donor Selection
4
2019
31
1.700
Why?
Humans
114
2020
28998
1.580
Why?
Retrospective Studies
31
2019
3100
1.540
Why?
Kidney
14
2020
485
1.470
Why?
Organ Preservation
6
2014
13
1.410
Why?
Regenerative Medicine
12
2015
187
1.380
Why?
Tissue and Organ Harvesting
6
2014
35
1.360
Why?
Adult
46
2020
8391
1.350
Why?
Antibodies, Monoclonal
8
2009
196
1.350
Why?
Middle Aged
50
2020
10805
1.310
Why?
Regeneration
10
2016
167
1.270
Why?
Organ Transplantation
8
2013
65
1.240
Why?
Cadaver
12
2018
143
1.190
Why?
Male
54
2020
17767
1.170
Why?
Female
55
2020
18112
1.130
Why?
Nephrectomy
5
2019
114
1.110
Why?
Tissue Engineering
10
2016
607
1.050
Why?
Postoperative Complications
7
2018
670
1.040
Why?
Follow-Up Studies
16
2019
2105
0.970
Why?
Survival Rate
11
2018
795
0.920
Why?
Patient Selection
8
2018
257
0.920
Why?
Transplantation, Homologous
10
2014
113
0.900
Why?
Diabetes Mellitus
3
2015
360
0.890
Why?
Liver Transplantation
13
2012
111
0.860
Why?
Tissue Scaffolds
12
2016
385
0.860
Why?
Time Factors
19
2017
1997
0.850
Why?
Cytomegalovirus Infections
5
2014
25
0.810
Why?
Extracellular Matrix
9
2016
226
0.800
Why?
C-Peptide
3
2018
25
0.790
Why?
Isoantibodies
3
2014
10
0.780
Why?
Mycophenolic Acid
6
2008
28
0.780
Why?
Bioengineering
9
2015
67
0.770
Why?
Cold Ischemia
2
2018
7
0.740
Why?
Treatment Outcome
21
2017
3094
0.730
Why?
Extracorporeal Circulation
2
2011
11
0.730
Why?
Tacrolimus
10
2008
44
0.720
Why?
Living Donors
5
2015
51
0.720
Why?
Immunoglobulin G
4
2004
104
0.710
Why?
Diabetes Mellitus, Type 1
10
2014
180
0.710
Why?
Portal Vein
2
2013
16
0.710
Why?
Antibodies, Neoplasm
3
2009
12
0.700
Why?
Aged
20
2019
9461
0.690
Why?
Steroids
3
2015
36
0.690
Why?
Prognosis
9
2018
1362
0.660
Why?
Endarterectomy
1
2018
7
0.660
Why?
Renal Artery
1
2018
43
0.650
Why?
Antiviral Agents
5
2010
100
0.650
Why?
Health Services Accessibility
3
2017
231
0.650
Why?
Risk Factors
14
2018
3509
0.640
Why?
Carcinoma, Renal Cell
2
2019
108
0.560
Why?
Young Adult
9
2019
2398
0.540
Why?
Renal Insufficiency
2
2017
53
0.530
Why?
Kidney Neoplasms
2
2019
191
0.530
Why?
Drainage
2
2013
49
0.520
Why?
Uremia
1
2015
9
0.520
Why?
Kidney Diseases
3
2014
239
0.520
Why?
Embolization, Therapeutic
2
2019
79
0.520
Why?
Ganciclovir
4
2008
14
0.520
Why?
Transplantation Conditioning
1
2014
11
0.510
Why?
Pancreas
6
2016
79
0.510
Why?
Radiography, Interventional
1
2014
35
0.500
Why?
Ossification, Heterotopic
1
2014
14
0.500
Why?
Glomerular Filtration Rate
6
2018
286
0.490
Why?
Gastrointestinal Tract
3
2012
29
0.480
Why?
North Carolina
6
2018
1422
0.460
Why?
Animals
18
2015
7296
0.460
Why?
Perfusion
4
2015
64
0.440
Why?
Incidence
6
2018
1105
0.440
Why?
Catheter Ablation
1
2013
62
0.440
Why?
Azathioprine
3
2011
8
0.430
Why?
Polyomavirus Infections
4
2006
21
0.420
Why?
Death, Sudden, Cardiac
2
2020
59
0.420
Why?
Adolescent
9
2019
3248
0.420
Why?
Death
2
2009
41
0.420
Why?
Age Factors
7
2019
1105
0.420
Why?
Transplantation Tolerance
1
2011
14
0.420
Why?
Kidney Function Tests
3
2018
102
0.420
Why?
Reoperation
6
2019
203
0.410
Why?
Gout
1
2011
14
0.410
Why?
Thiazoles
1
2011
32
0.410
Why?
Thrombosis
1
2012
60
0.410
Why?
Fibrinolytic Agents
1
2012
70
0.410
Why?
Thrombectomy
1
2012
58
0.400
Why?
Heart Arrest
1
2011
39
0.390
Why?
Anticoagulants
1
2012
120
0.390
Why?
Sirolimus
3
2008
35
0.370
Why?
Prospective Studies
6
2018
2010
0.350
Why?
Creatinine
5
2016
173
0.350
Why?
Islets of Langerhans Transplantation
4
2014
40
0.340
Why?
Blood Group Incompatibility
3
2016
11
0.340
Why?
ABO Blood-Group System
3
2016
19
0.330
Why?
Insulin
4
2018
346
0.290
Why?
Child, Preschool
4
2019
1164
0.290
Why?
Tumor Virus Infections
2
2004
20
0.290
Why?
Survival Analysis
7
2019
440
0.280
Why?
Stem Cell Transplantation
5
2015
203
0.280
Why?
Anemia, Hemolytic
1
2005
6
0.270
Why?
United States
7
2017
3604
0.270
Why?
Erythrocytes
1
2005
43
0.270
Why?
Rabbits
3
2014
185
0.260
Why?
Hypertension
1
2011
899
0.250
Why?
Diabetic Nephropathies
1
2005
195
0.240
Why?
Infant
4
2019
967
0.230
Why?
Nephritis, Interstitial
1
2003
9
0.230
Why?
Hepatitis C
2
2019
38
0.220
Why?
Prednisone
1
2002
43
0.210
Why?
Registries
2
2016
278
0.210
Why?
Academic Medical Centers
1
2003
150
0.210
Why?
Postoperative Period
2
2014
91
0.200
Why?
Anti-Inflammatory Agents
1
2002
90
0.200
Why?
Child
3
2019
2209
0.200
Why?
Chi-Square Distribution
3
2017
292
0.190
Why?
Length of Stay
2
2014
291
0.190
Why?
Cyclosporine
5
1993
34
0.180
Why?
RNA
1
2020
88
0.170
Why?
Aged, 80 and over
2
2017
3712
0.170
Why?
Antibodies
1
1998
53
0.170
Why?
Acyclovir
1
1998
8
0.170
Why?
Hypoglycemia
1
1998
41
0.170
Why?
Gene Expression Profiling
1
2020
320
0.160
Why?
Treatment Failure
2
2017
159
0.160
Why?
Biopsy
4
2014
241
0.160
Why?
Cohort Studies
3
2011
1674
0.160
Why?
Odds Ratio
2
2016
446
0.150
Why?
Apolipoproteins
2
2016
196
0.150
Why?
Blood Transfusion
2
2014
64
0.140
Why?
Islets of Langerhans
2
2016
74
0.140
Why?
Lipoproteins, HDL
2
2016
247
0.140
Why?
Bioreactors
2
2013
59
0.140
Why?
Microvessels
1
2015
23
0.140
Why?
Healthcare Disparities
1
2017
153
0.130
Why?
Kidney Glomerulus
1
2015
30
0.130
Why?
Caveolin 1
1
2015
13
0.130
Why?
Brain Death
2
2014
27
0.130
Why?
Preoperative Period
1
2014
31
0.130
Why?
Intercellular Signaling Peptides and Proteins
1
2015
100
0.130
Why?
Hemodynamics
1
2015
148
0.130
Why?
Metaplasia
1
2014
20
0.130
Why?
HLA Antigens
2
2014
35
0.130
Why?
Blood Loss, Surgical
1
2014
45
0.130
Why?
Immune Tolerance
2
2014
67
0.120
Why?
Insulin-Secreting Cells
1
2014
53
0.120
Why?
Bioprosthesis
1
2014
55
0.120
Why?
Acute Disease
4
2012
239
0.120
Why?
Preoperative Care
1
2014
110
0.120
Why?
Regional Blood Flow
1
2013
82
0.120
Why?
Organ Culture Techniques
1
2013
38
0.120
Why?
Insurance Coverage
1
2013
74
0.110
Why?
Disease Progression
1
2014
572
0.110
Why?
Abdomen
1
2012
42
0.110
Why?
Intestines
2
2010
54
0.110
Why?
Kidney Tubular Necrosis, Acute
1
1992
2
0.110
Why?
Liver
2
2012
464
0.110
Why?
Drug Administration Schedule
2
2003
246
0.110
Why?
Diabetes Mellitus, Type 2
2
2011
1374
0.110
Why?
Waiting Lists
2
2013
30
0.110
Why?
Cells, Cultured
1
2014
799
0.110
Why?
Blood Grouping and Crossmatching
2
2016
9
0.110
Why?
Warfarin
1
2012
30
0.110
Why?
Postoperative Hemorrhage
1
2012
38
0.100
Why?
Gastrointestinal Diseases
1
2012
38
0.100
Why?
Gout Suppressants
1
2011
4
0.100
Why?
Aspirin
1
2012
61
0.100
Why?
Drug Therapy, Combination
2
2003
273
0.100
Why?
Hepatitis, Viral, Human
1
1991
4
0.100
Why?
Heparin
1
2012
75
0.100
Why?
Drug Interactions
1
2011
80
0.100
Why?
African Americans
2
2016
1373
0.100
Why?
Warm Ischemia
1
2011
8
0.100
Why?
General Surgery
1
2012
81
0.100
Why?
Transplantation Immunology
4
2015
27
0.100
Why?
Polymorphism, Single Nucleotide
1
2015
1079
0.100
Why?
Ethnic Groups
1
2013
440
0.100
Why?
Cost-Benefit Analysis
1
2010
159
0.090
Why?
Immunotherapy
1
2010
67
0.090
Why?
Proportional Hazards Models
3
2017
706
0.090
Why?
Serum Albumin
1
2010
53
0.090
Why?
Solutions
1
2009
26
0.090
Why?
Hyperglycemia
1
2010
82
0.090
Why?
Stem Cells
4
2014
292
0.090
Why?
Risk Assessment
2
2017
1300
0.090
Why?
Glomerulonephritis, IGA
1
2009
6
0.090
Why?
Asphyxia
1
2009
6
0.090
Why?
Infarction
1
2009
5
0.090
Why?
Suicide
1
2009
17
0.090
Why?
T-Lymphocytes
1
2009
114
0.090
Why?
Leukopenia
1
2008
7
0.090
Why?
Cause of Death
2
2007
219
0.080
Why?
Ischemia
1
2009
92
0.080
Why?
Compartment Syndromes
1
2009
38
0.080
Why?
Randomized Controlled Trials as Topic
1
2011
462
0.080
Why?
Diabetes Complications
1
2010
171
0.080
Why?
Inflammation
1
2012
503
0.080
Why?
Intraoperative Period
1
2007
37
0.080
Why?
Case-Control Studies
2
2007
855
0.080
Why?
Age Distribution
1
2007
197
0.080
Why?
Cryopreservation
1
2007
42
0.070
Why?
Body Size
1
2006
31
0.070
Why?
Multivariate Analysis
3
2017
636
0.070
Why?
Nephrons
1
2006
10
0.070
Why?
Polyomavirus
1
2006
1
0.070
Why?
Rho(D) Immune Globulin
1
2005
2
0.070
Why?
Glycosuria, Renal
1
2005
3
0.070
Why?
Hemolysis
1
2005
12
0.070
Why?
Anastomosis, Surgical
2
2003
49
0.070
Why?
Organogenesis
2
2016
15
0.070
Why?
Lymphocytes
1
2005
53
0.070
Why?
Quality of Health Care
1
2006
134
0.070
Why?
Drug Monitoring
1
2004
24
0.060
Why?
BK Virus
1
2004
7
0.060
Why?
Phenotype
2
2016
629
0.060
Why?
Portal System
1
2003
6
0.060
Why?
Attitude to Health
1
2004
147
0.060
Why?
Triglycerides
1
2004
214
0.060
Why?
Digestive System Surgical Procedures
1
2003
20
0.060
Why?
Transplants
2
2014
22
0.060
Why?
Liver Regeneration
2
2012
23
0.050
Why?
Cholesterol
1
2004
229
0.050
Why?
Muromonab-CD3
4
2002
5
0.050
Why?
Quality of Life
3
2015
814
0.050
Why?
Bile Ducts
1
2001
18
0.050
Why?
Histocompatibility Testing
2
2014
15
0.050
Why?
Biocompatible Materials
2
2012
210
0.050
Why?
Cold Temperature
1
2001
39
0.050
Why?
Databases, Factual
2
2017
331
0.050
Why?
Long-Term Care
1
2000
21
0.050
Why?
Remission, Spontaneous
1
2019
14
0.040
Why?
RNA, Viral
1
2019
49
0.040
Why?
Angiography
1
2019
75
0.040
Why?
Hepacivirus
1
2019
37
0.040
Why?
Viral Load
1
2019
64
0.040
Why?
Tennessee
1
1998
97
0.040
Why?
Costs and Cost Analysis
1
1998
88
0.040
Why?
Administration, Oral
1
1998
169
0.040
Why?
Neoplasm Staging
1
2019
436
0.040
Why?
Blood Glucose
1
1998
465
0.030
Why?
Protein Array Analysis
1
2015
16
0.030
Why?
Corrosion Casting
1
2015
9
0.030
Why?
Receptors, Vascular Endothelial Growth Factor
1
2015
20
0.030
Why?
Social Support
1
2017
163
0.030
Why?
Microscopy, Electron, Scanning
1
2015
91
0.030
Why?
Vascular Endothelial Growth Factor A
1
2015
102
0.030
Why?
Genetic Association Studies
1
2015
148
0.030
Why?
Haplotypes
1
2015
220
0.030
Why?
Tomography, X-Ray Computed
1
2019
871
0.030
Why?
Cross-Sectional Studies
1
1998
1353
0.030
Why?
Genotype
1
2016
735
0.030
Why?
Forecasting
1
2014
133
0.030
Why?
Antigens
1
2013
31
0.030
Why?
Magnetic Resonance Imaging
1
2019
1216
0.030
Why?
Detergents
1
2013
17
0.030
Why?
Chickens
1
2013
40
0.030
Why?
Pressure
1
2013
54
0.030
Why?
Sus scrofa
1
2013
44
0.030
Why?
Quality Assurance, Health Care
2
2004
61
0.030
Why?
Capsules
1
2012
14
0.030
Why?
Neovascularization, Physiologic
1
2013
106
0.030
Why?
Renal Circulation
1
1992
13
0.030
Why?
Skin, Artificial
1
2012
31
0.030
Why?
Larynx
1
2012
19
0.030
Why?
Chondroitin Sulfates
1
2012
22
0.030
Why?
Hepatocytes
1
2012
74
0.030
Why?
Vascular Resistance
1
1992
28
0.030
Why?
Respiratory Tract Diseases
1
2012
30
0.030
Why?
Pancreatic Diseases
1
2012
16
0.030
Why?
Liver Failure
1
2012
17
0.030
Why?
Intestinal Diseases
1
2012
18
0.030
Why?
Dogs
1
1992
117
0.030
Why?
Cell Differentiation
1
2014
436
0.030
Why?
Swine
1
2012
201
0.030
Why?
Cell Transplantation
1
2012
63
0.030
Why?
Blood Vessel Prosthesis
1
2012
78
0.030
Why?
Developmental Biology
1
2011
7
0.030
Why?
Antigens, Differentiation, T-Lymphocyte
1
1991
5
0.030
Why?
Immunohistochemistry
1
2013
519
0.030
Why?
Receptors, Antigen, T-Cell
1
1991
21
0.030
Why?
T-Lymphocyte Subsets
1
1991
22
0.030
Why?
Cattle
1
2011
100
0.030
Why?
History, 20th Century
1
2011
68
0.030
Why?
Corneal Transplantation
1
2010
13
0.020
Why?
Collagen
1
2012
216
0.020
Why?
Chondrocytes
1
2011
71
0.020
Why?
Wound Healing
1
2012
182
0.020
Why?
Cell Proliferation
1
2013
573
0.020
Why?
European Continental Ancestry Group
1
2015
1131
0.020
Why?
Trachea
1
2010
55
0.020
Why?
Ultrasonography
1
1992
345
0.020
Why?
Heart
1
2010
161
0.020
Why?
Wounds and Injuries
1
2012
249
0.020
Why?
Transplantation
1
1989
12
0.020
Why?
Granulocyte Colony-Stimulating Factor
1
2008
21
0.020
Why?
Hypoglycemic Agents
1
2010
175
0.020
Why?
Models, Biological
1
2010
372
0.020
Why?
Chronic Disease
3
1993
369
0.020
Why?
Sex Factors
2
2004
626
0.020
Why?
Heart Failure
1
2012
567
0.020
Why?
Necrosis
1
2006
52
0.020
Why?
Drug Therapy
1
2006
16
0.020
Why?
Mice
1
2011
2368
0.020
Why?
Disease Management
1
2006
114
0.020
Why?
Factor Analysis, Statistical
1
2004
70
0.020
Why?
Heart Transplantation
1
2004
26
0.020
Why?
Needs Assessment
1
2004
66
0.020
Why?
Health Surveys
1
2004
191
0.020
Why?
Psychometrics
1
2004
129
0.010
Why?
Antineoplastic Agents
1
2008
546
0.010
Why?
Liver Function Tests
2
1993
19
0.010
Why?
Morbidity
1
2002
91
0.010
Why?
Mortality
1
2003
108
0.010
Why?
Disease-Free Survival
1
2002
281
0.010
Why?
Adrenal Cortex Hormones
2
1993
148
0.010
Why?
Risk
1
2002
289
0.010
Why?
Severity of Illness Index
1
2004
863
0.010
Why?
Hepatectomy
1
2001
66
0.010
Why?
Actuarial Analysis
1
1993
4
0.010
Why?
Bilirubin
1
1993
22
0.010
Why?
Communicable Diseases
1
1993
19
0.010
Why?
Drug Resistance
1
1993
36
0.010
Why?
Sex Characteristics
1
1993
166
0.010
Why?
Analysis of Variance
1
1993
454
0.010
Why?
Renal Dialysis
1
1993
259
0.010
Why?
Antibody-Dependent Cell Cytotoxicity
1
1989
3
0.010
Why?
Wisconsin
1
1989
18
0.010
Why?
California
1
1989
60
0.010
Why?
Pregnancy
1
1989
807
0.000
Why?
Stratta's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (336)
Explore
_
Co-Authors (33)
Explore
_
Similar People (52)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_